FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3033893556> ?p ?o ?g. }

• W3033893556 abstract "The aim and objective of this research work was to formulate and evaluate Piroxicam Emugel for topical drug delivery. Various concentration of gelling agent were used for preparation of Piroxicam Emugel along with emulsifiers Tween-80 and Span-80 with glycerine as a humectants. The Clove oil and eucalyptus oil were used as permeation enhancer. The formulated Emulgel was characterized for their physical appearance, pH determination, spreadability, extrudability, drug content, in vitro drug release and stability studies. According to our results, the range of pH of the formulations was from 5.6±0.2 to 6.8±0.3 for final batches which is considered acceptable. Formulation F3, F4, F6 and F7 spreadability was found to be 32.03 ± 0.54 g.cm/sec, 30.79±0.2 g.cm/sec, 26.41±0.51 g.cm/sec and 30.44±0.6 g.cm/sec respectively. The Formulation F5 and F8 was prepared with higher concentration of carbopol i.e. 1.5 g were of in stiff category and the spreadabilty value found to be 18.14±0.36 g.cm/sec and 20.30±0.34 g.cm/sec respectively. The percentage swelling index was (F5, F6, F7 and F8) found to be 44.24 %, 27.35%, 31.98 % and 46.38 respectively. Extrudability of Formulation F5 and F8 was less i.e. 17.32± 0.5 gm/cm2 and 20.39±0.58 gm/cm2 respectively as containing higher concentration of polymer. Formulation F3, F4, F6, F7 having optimum concentration of polymer extrudability was good i.e. 30.47±0.52 gm/cm2, 27.39±0.6 gm/cm2, 29.49±0.56 gm/cm2 and 26.90±0.6 gm/cm2 respectively. Extrudability was decreased with an increase in concentration of Carbopol. Invitro drug release (98.45% in 8h) from the Emulgel, batch F7 was concluded as optimized batch. Drug release was in following order F5< F1< F3< F2< F4< F8 < F6 < F7. Presence of two Penetration enhancer’s Clove oil and Eucalyptus oil has resulted in better performance as compared to other formulations. All these developed emugel formulation have acceptable physical properties, hence F7 can be considered as the optimized formulation. From this research, the formulated Emulgel of Piroxicam would be an effective alternative to conventional delivery of Piroxicam for the management of pain and inflammation." @default.
• W3033893556 created "2020-06-12" @default.
• W3033893556 creator A5009465794 @default.
• W3033893556 creator A5020565620 @default.
• W3033893556 creator A5027815981 @default.
• W3033893556 creator A5042428953 @default.
• W3033893556 creator A5047011573 @default.
• W3033893556 creator A5061382358 @default.
• W3033893556 date "2022-06-24" @default.
• W3033893556 modified "2023-09-25" @default.
• W3033893556 title "Formulation and Characterization of Piroxicam Emulgel for Topical Drug Delivery" @default.
• W3033893556 doi "https://doi.org/10.22376/ijpbs/lpr.2020.10.2.p46-54" @default.
• W3033893556 hasPublicationYear "2022" @default.
• W3033893556 type Work @default.
• W3033893556 sameAs 3033893556 @default.
• W3033893556 citedByCount "0" @default.
• W3033893556 crossrefType "journal-article" @default.
• W3033893556 hasAuthorship W3033893556A5009465794 @default.
• W3033893556 hasAuthorship W3033893556A5020565620 @default.
• W3033893556 hasAuthorship W3033893556A5027815981 @default.
• W3033893556 hasAuthorship W3033893556A5042428953 @default.
• W3033893556 hasAuthorship W3033893556A5047011573 @default.
• W3033893556 hasAuthorship W3033893556A5061382358 @default.
• W3033893556 hasBestOaLocation W30338935561 @default.
• W3033893556 hasConcept C142724271 @default.
• W3033893556 hasConcept C185592680 @default.
• W3033893556 hasConcept C204787440 @default.
• W3033893556 hasConcept C2778139025 @default.
• W3033893556 hasConcept C2778540859 @default.
• W3033893556 hasConcept C2780035454 @default.
• W3033893556 hasConcept C2781131970 @default.
• W3033893556 hasConcept C31903555 @default.
• W3033893556 hasConcept C41625074 @default.
• W3033893556 hasConcept C43617362 @default.
• W3033893556 hasConcept C50670333 @default.
• W3033893556 hasConcept C55493867 @default.
• W3033893556 hasConcept C71924100 @default.
• W3033893556 hasConcept C98274493 @default.
• W3033893556 hasConceptScore W3033893556C142724271 @default.
• W3033893556 hasConceptScore W3033893556C185592680 @default.
• W3033893556 hasConceptScore W3033893556C204787440 @default.
• W3033893556 hasConceptScore W3033893556C2778139025 @default.
• W3033893556 hasConceptScore W3033893556C2778540859 @default.
• W3033893556 hasConceptScore W3033893556C2780035454 @default.
• W3033893556 hasConceptScore W3033893556C2781131970 @default.
• W3033893556 hasConceptScore W3033893556C31903555 @default.
• W3033893556 hasConceptScore W3033893556C41625074 @default.
• W3033893556 hasConceptScore W3033893556C43617362 @default.
• W3033893556 hasConceptScore W3033893556C50670333 @default.
• W3033893556 hasConceptScore W3033893556C55493867 @default.
• W3033893556 hasConceptScore W3033893556C71924100 @default.
• W3033893556 hasConceptScore W3033893556C98274493 @default.
• W3033893556 hasLocation W30338935561 @default.
• W3033893556 hasOpenAccess W3033893556 @default.
• W3033893556 hasPrimaryLocation W30338935561 @default.
• W3033893556 hasRelatedWork W1984235435 @default.
• W3033893556 hasRelatedWork W2064305315 @default.
• W3033893556 hasRelatedWork W2087302966 @default.
• W3033893556 hasRelatedWork W2121828422 @default.
• W3033893556 hasRelatedWork W2122594612 @default.
• W3033893556 hasRelatedWork W2140764624 @default.
• W3033893556 hasRelatedWork W2159054627 @default.
• W3033893556 hasRelatedWork W2348106968 @default.
• W3033893556 hasRelatedWork W2887566000 @default.
• W3033893556 hasRelatedWork W2158968817 @default.
• W3033893556 isParatext "false" @default.
• W3033893556 isRetracted "false" @default.
• W3033893556 magId "3033893556" @default.
• W3033893556 workType "article" @default.